Loading clinical trials...

Prevalence of Sarcopenia in Patients Admitted to ICU and Its Progression During Hospitalization. | Clinical Trials | Clareo Health

ENROLLING_BY_INVITATION

Prevalence of Sarcopenia in Patients Admitted to ICU and Its Progression During Hospitalization.

NCT07303335•Hospital Mutua de Terrassa

View on ClinicalTrials.gov

Summary

This is a prospective, observational study at the ICU of Hospital Mútua de Terrassa, running from May to December 2025. The primary goal is to determine the prevalence of sarcopenia in adult patients requiring more than 48 hours of mechanical ventilation. Sarcopenia is assessed using the SARC-F score, impedanciometry, and quadriceps ultrasound. Secondary aims include tracking the development of ICU-Acquired Weakness (ICU-AW) using the MRC score. All data is collected anonymously after obtaining informed consent.

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Older than 18 years old.
•Expected duration of mechanical ventilation (MV) exceeding 48 hours.

Exclusion Criteria

•Refusal to participate.
•Mechanical ventilation not exceeding 48 hours.
•Do-not-resuscitate (DNR) orders or limitations of therapeutic effort upon admission.

Locations (1)

Hospital Universitari Mútua Terrassa

Terrassa, Barcelona, Spain

Key Dates

Start Date

May 14, 2025

Primary Completion Date

December 31, 2025

Completion Date

February 1, 2026

Last Updated

December 24, 2025

Enrollment

100

ESTIMATED participants

Conditions

SarcopeniaCritical IllnessIntensive Care (ICU) MyopathyBody Composition MeasurementBio-Impedance MeasurementsUltrasound Evaluation

The Intensive Care Platform Trial

NCT06667999

Intensive Care PatientsIntensive Care Unit Patients+1 more

View study

RECRUITINGNA

Effect of Essential Aminoacid Supplementation and Exercise on Skeletal Muscle Function in Hemodialysis Patients

NCT05884138

Sarcopenia

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 24, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Prevalence of Sarcopenia in Patients Admitted to ICU and Its Progression During Hospitalization.

Inclusion Criteria

Exclusion Criteria

The Intensive Care Platform Trial

Effect of Essential Aminoacid Supplementation and Exercise on Skeletal Muscle Function in Hemodialysis Patients

Assessing Fluid-responsiveness Using Non-invasive Hybrid Diffuse Optics on Peripheral Muscle

Transcutaneous pO₂ Monitoring in PICU

A Multi-Center Data System and Collaborative Network in China for Severe Infection and Sepsis Children

Treatment Strategy of Human Gamma Globulin on the Therapy for Intensively Ill Children With Inflammatory Storm